Lichen China Limited Class A Ordinary Shares

LICN

Lichen China Limited Class A Ordinary Shares (LICN) is a company involved in the distribution, marketing, and sale of personal care, household products, and other consumer goods in China. The company focuses on leveraging its extensive distribution network and marketing expertise to reach a broad customer base across various channels in China’s rapidly growing consumer market.

$3.00 -0.02 (-0.66%)
🚫 Lichen China Limited Class A Ordinary Shares does not pay dividends

Company News

Univest Securities, LLC Announces Closing of $3.4 Million Registered Direct Offering for its Client Lichen China Limited (NASDAQ: LICN)
GlobeNewswire Inc. • N/A • January 29, 2025

Univest Securities, LLC announced the closing of a $3.4 million registered direct offering for its client Lichen China Limited, a financial and taxation service provider. The offering involved the sale of 42.5 million shares of Lichen China's Class A ordinary shares.

Univest Securities, LLC Announces Closing of $2.8 Million Registered Direct Offering for its Client Lichen China Limited (NASDAQ: LICN)
GlobeNewswire Inc. • N/A • December 27, 2024

Univest Securities, LLC announced the closing of a $2.8 million registered direct offering for its client Lichen China Limited, a financial and taxation service provider.

Univest Securities, LLC Announces Closing of $2.7 Million Registered Direct Offering for its Client Lichen China Limited (NASDAQ: LICN)
GlobeNewswire Inc. • N/A • December 13, 2024

Univest Securities, LLC announced the closing of a $2.7 million registered direct offering for its client Lichen China Limited, a financial and taxation service provider. The offering involved the sale of 15,000,000 shares of the company's Class A ordinary shares.

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga • Avi Kapoor • March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) and Landos Biopharma, reported a definitive agreement under which AbbVie will acquire Landos. Landos Biopharma shares jumped 171.2% to $21.70 on Monday. Here are some other stocks moving in today's mid-day s...

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga • Avi Kapoor • February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results. Fluor posted adjusted earnings of 68 cents per share, beating market estimates of 57 cents per share. The company’s quarterly sales came in at $3.82 billion versus expectations of $4.11 billion. Fluor shares declined 7.7% to $38.84 on Tues...

Related Companies